Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

The treatment cleared psoriasis in some patients but caused side effects in most.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Minoxidil effectively promotes hair growth in seborrheic alopecia.

Finasteride can cause melasma, especially in people with darker skin.

Orlistat might block the body's ability to absorb thyroid medication.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The antidepressant escitalopram likely caused hair loss in a patient.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

AGA patients have higher insulin resistance and serum progranulin levels, suggesting a link to metabolic issues.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.